Moderna Shares Spike After Company Says Its Covid Booster Increases Antibody Levels Against Omicron

Published on December 20, 2021

The company also has plans to continue the development of a booster specifically targeting Omicron, which is expected to enter clinical trials in early 2022. 

Continue reading on website
Other news

Markets Sell Again: Omicron, the Fed & More

December 20, 2021
The Omicron variant of Covid-19 is changing the calculus of the global economy.

Add Value to Your Portfolio With These 4 Low P/CF Stocks

December 20, 2021
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Kohl's Corporation (KSS), Berry Global (BERY), Atlas Corp. (ATCO) and DXC Technology (DXC) boast low P/CF...